Literature DB >> 11251568

Familial clustering of polymorphic light eruption in relatives of patients with lupus erythematosus: evidence of a shared pathogenesis.

T P Millard1, C M Lewis, M A Khamashta, G R Hughes, J L Hawk, J M McGregor.   

Abstract

BACKGROUND: Abnormal photosensitivity is a common feature of many forms of lupus erythematosus (LE).
OBJECTIVES: To examine the role of polymorphic light eruption (PLE) as a possible predisposing factor for cutaneous forms of LE.
METHODS: Eighty-five patients with well-characterized subacute cutaneous LE (SCLE) and discoid LE (DLE) were recruited from outpatient clinics, and the prevalence of PLE determined by detailed interview and clinical examination.
RESULTS: Symptoms consistent with PLE were reported in 61% and 55% of SCLE and DLE patients, respectively; this was significantly higher than the overall population prevalence of 13.6% (P < 0.001), giving a relative risk (RR) for PLE in SCLE patients of 3.37 (95% confidence interval, CI 2.46--4.28) and DLE patients of 3.11 (95% CI 2.31--3.91). PLE developed before the onset of LE in 61% of cases (median interval 12 years, range 1--40), concomitantly in 24%, and subsequently in a further 15% (median interval 3.5 years, range 1--25). To delineate the relationship between PLE and LE further, the prevalence of PLE was determined in 103 otherwise unaffected first-degree relatives of SCLE and DLE probands; we had previously demonstrated clustering of PLE in families, reflecting a strong genetic component. We found a significantly higher PLE prevalence in relatives of the LE probands than in the general population (P < 0.001), giving an RR for PLE of 2.29 (95% CI 1.55--3.03) and 2.61 (95% CI 1.32--3.89) for female and male relatives, respectively.
CONCLUSIONS: The high prevalence of PLE in LE patients, together with clustering of PLE among first-degree relatives of SCLE and DLE probands, suggests that there may be a shared pathogenetic basis for PLE and cutaneous LE. We propose that predisposition to PLE may contribute to the LE phenotype in otherwise susceptible individuals.

Entities:  

Mesh:

Year:  2001        PMID: 11251568     DOI: 10.1046/j.1365-2133.2001.03897.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  [Cutaneous lupus erythematosus. Part 2: diagnostics and therapy].

Authors:  A Kuhn; K Gensch; S Ständer; G Bonsmann
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

2.  Characterization of clinical photosensitivity in cutaneous lupus erythematosus.

Authors:  Kristen Foering; Aileen Y Chang; Evan W Piette; Andrew Cucchiara; Joyce Okawa; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2013-05-03       Impact factor: 11.527

3.  Levels and function of regulatory T cells in patients with polymorphic light eruption: relation to photohardening.

Authors:  N Schweintzger; A Gruber-Wackernagel; E Reginato; I Bambach; F Quehenberger; S N Byrne; P Wolf
Journal:  Br J Dermatol       Date:  2015-07-30       Impact factor: 9.302

4.  Influence of the season on vitamin D levels and regulatory T cells in patients with polymorphic light eruption.

Authors:  N A Schweintzger; A Gruber-Wackernagel; N Shirsath; F Quehenberger; B Obermayer-Pietsch; P Wolf
Journal:  Photochem Photobiol Sci       Date:  2016-02-25       Impact factor: 3.982

5.  CD123 immunoexpression in cutaneous lupus erythematosus, polymorphous light eruption, pityriasis rosea, and mycosis fungoides.

Authors:  Ebru Karagun; Mehmet Gamsizkan; Seyma Buyucek; Sinem Coskun
Journal:  Postepy Dermatol Alergol       Date:  2022-01-07       Impact factor: 1.837

6.  Long-Term Course of Polymorphic Light Eruption: A Registry Analysis.

Authors:  Alexandra Gruber-Wackernagel; Tanja Schug; Thomas Graier; Franz J Legat; Hanna Rinner; Angelika Hofer; Franz Quehenberger; Peter Wolf
Journal:  Front Med (Lausanne)       Date:  2021-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.